Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE 2/EP2 signaling

Journal of Experimental Medicine

Volumn 206, Issue 1, 2009, Pages 61-68

  Medeiros, Alexandra I ^a   Serezani, Carlos H ^a   Lee, Sang Pyo ^a,b   Peters Golden, Marc ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Gachon University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; INTERLEUKIN 10; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTANOID RECEPTOR; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN EP2 RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; APOPTOSIS; ARTICLE; BACTERICIDAL ACTIVITY; CELL FUNCTION; DISEASE SEVERITY; EFFEROCYTOSIS; ENZYME SYNTHESIS; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; LEUKOCYTE; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; MOUSE; NONHUMAN; PHAGOCYTOSIS; PNEUMONIA; PRIORITY JOURNAL; RAT; STREPTOCOCCUS PNEUMONIAE; ANIMAL; C57BL MOUSE; CULTURE MEDIUM; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; LEUKEMIA CELL LINE; LUNG; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; NEUTROPHIL; PHYSIOLOGY; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIA; T LYMPHOCYTE; WISTAR RAT;

ADENYLATE CYCLASE; ANIMALS; APOPTOSIS; CULTURE MEDIA, CONDITIONED; CYCLIC AMP; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; HUMANS; INTERLEUKIN-10; JURKAT CELLS; LUNG; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; PHAGOCYTOSIS; PNEUMONIA, PNEUMOCOCCAL; PROSTAGLANDIN ANTAGONISTS; RATS; RATS, WISTAR; RECEPTORS, PROSTAGLANDIN E; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE; T-LYMPHOCYTES;

EID: 60549103394     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20082058     Document Type: Article

References (36)

1. Wheeler, A.P., and G.R. Bernard. 2007. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet. 369:1553-1564.
2. Matute-Bello, G., and T.R. Martin. 2003. Science review: apoptosis in acute lung injury. Crit. Care. 7:355-358.
3. Fadok, V.A., D.L. Bratton, A. Konowal, P.W. Freed, J.Y. Westcott, and P.M. Henson. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/ paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101:890-898.
4. Voll, R.E., M. Herrmann, E.A. Roth, C. Stach, J.R. Kalden, and I. Girkontaite. 1997. Immunosuppressive effects of apoptotic cells. Nature. 390:350-351.
5. McDonald, P.P., V.A. Fadok, D. Bratton, and P.M. Henson. 1999. Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells. J. Immunol. 163:6164-6172.
6. Huynh, M.L., V.A. Fadok, and P.M. Henson. 2002. Phosphatidylserine- dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 109:41-50.
7. Sutherland, K.R., K.P. Steinberg, R.J. Maunder, J.A. Milberg, D.L. Allen, and L.D. Hudson. 1995. Pulmonary infection during the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 152:550-556.
8. Ravetch, J.V., and S. Bolland. 2001. I gG Fc receptors. Annu. Rev. Immunol. 19:275-290.
9. Cox, D., and S. Greenberg. 2001. Phagocytic signaling strategies: Fc(gamma)receptor-mediated phagocytosis as a model system. Semin. Immunol. 13:339-345.
10. Hu, B., J. Sonstein, P.J. Christensen, A. Punturieri, and J.L. Curtis. 2000. Deficient in vitro and in vivo phagocytosis of apoptotic T cells by resident murine alveolar macrophages. J. Immunol. 165:2124-2133.
11. Chen, W., M.E. Frank, W. Jin, and S.M. Wahl. 2001. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity. 14:715-725.
12. Freire-de-Lima, C.G., D.O. Nascimento, M.B. Soares, P.T. Bozza, H.C. Castro-Faria-Neto, F.G. de Mello, G.A. DosReis, and M.F. Lopes. 2000. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature. 403:199-203.
13. Diaz,A.,J.Varga, andS.A.Jimenez.1989.Transforming growth factor-beta stimulation of lung fibroblast prostaglandin E2 production. J. Biol. Chem. 264:11554-11557.
14. Aronoff, D.M., C. Canetti, and M. Peters-Golden. 2004. Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J. Immunol. 173:559-565.
15. Freire-de-Lima, C.G., Y.Q. Xiao, S.J. Gardai, D.L. Bratton, W.P. Schiemann, and P.M. Henson. 2006. Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. J. Biol. Chem. 281:38376-38384.
16. Ren, G., J. Su, X. Zhao, L. Zhang, J. Zhang, A.I. Roberts, H. Zhang, G. Das, and Y. Shi. 2008. Apoptotic cells induce immunosuppression through dendritic cells: critical roles of IFN-gamma and nitric oxide. J. Immunol. 181:3277-3284.
17. Aronoff, D.M., C. Canetti, C.H. Serezani, M. Luo, and M. Peters- Golden. 2005. Cutting edge: macrophage inhibition by cyclic AMP (cAMP): differential roles of protein kinase A and exchange protein directly activated by cAMP-1. J. Immunol. 174:595-599.
18. Serezani, C.H., J. Chung, M.N. Ballinger, B.B. Moore, D.M. Aronoff and M. Peters-Golden. 2007. Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase. Am. J. Respir. Cell Mol. Biol. 37:562-570.
19. Koedel, U., B. Angele, T. Rupprecht, H. Wagner, A. Roggenkamp, H.W. Pfister, and C.J. Kirschning. 2003. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J. Immunol. 170:438-444.
20. McNeely, T.B., and J.D. Coonrod. 1993. Comparison of the opsonic activity of human surfactant protein A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages. J. Infect. Dis. 167:91-97.
21. Arredouani, M., Z. Yang, Y. Ning, G. Qin, R. Soininen, K. Tryggvason, and L. Kobzik. 2004. The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J. Exp. Med. 200:267-272.
22. Mizgerd, J.P. 2006. Lung infection-a public health priority. PLoS Med. 3:e76.
23. Vandivier, R.W., V.A. Fadok, P.R. Hoffmann, D.L. Bratton, C. Penvari, K.K. Brown, J.D. Brain, F.J. Accurso, and P.M. Henson. 2002. Elastase- mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J. Clin. Invest. 109:661-670.
24. Kasahara, Y., R.M. Tuder, L. Taraseviciene-Stewart, T.D. Le Cras, S. Abman, P.K. Hirth, J. Waltenberger, and N.F. Voelkel. 2000. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest. 106:1311-1319.
25. Sibley, C.D., M.D. Parkins, H.R. Rabin, K. Duan, J.C. Norgaard, and M.G. Surette. 2008. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc. Natl. Acad. Sci. USA. 105:15070-15075.
26. Soler, N., C. Agusti, J. Angrill, J. Puig De la Bellacasa, and A. Torres. 2007. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease. Thorax. 62:29-35.
27. Hu, B., J.H. Jennings, J. Sonstein, J. Floros, J.C. Todt, T. Polak, and J.L. Curtis. 2004. Resident murine alveolar and peritoneal macrophages differ in adhesion of apoptotic thymocytes. Am. J. Respir. Cell Mol. Biol. 30:687-693.
28. Wilborn, J., D.L. DeWitt, and M. Peters-Golden. 1995. Expression and role of cyclooxygenase isoforms in alveolar and peritoneal macrophages. Am. J. Physiol. 268:L294-L301.
29. Hizaki, H., E. Segi, Y. Sugimoto, M. Hirose, T. Saji, F. Ushikubi, T. Matsuoka, Y. Noda, T. Tanaka, N. Yoshida, et al. 1999. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2). Proc. Natl. Acad. Sci. USA. 96:10501-10506.
30. Serezani, C.H., D.M. Aronoff, S. Jancar, and M. Peters-Golden. 2005. Leukotriene B4 mediates p47phox phosphorylation and membrane trans- location in polyunsaturated fatty acid-stimulated neutrophils. J. Leukoc. Biol. 78:976-984.
31. Canetti, C., B. Hu, J.L. Curtis, and M. Peters-Golden. 2003. Syk activation is a leukotriene B4-regulated event involved in macrophage phagocytosis of IgG-coated targets but not apoptotic cells. Blood. 102:1877-1883.
32. Peck, R. 1985. A one-plate assay for macrophage bactericidal activity. J. Immunol. Methods. 82:131-140.
33. Sadikot, R.T., H. Zeng, A.C. Azim, M. Joo, S.K. Dey, R.M. Breyer, R.S. Peebles, T.S. Blackwell, and J.W. Christman. 2007. Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX-2. Eur. J. Immunol. 37:1001-1009.
34. Aronoff, D.M., C.M. Peres, C.H. Serezani, M.N. Ballinger, J.K. Carstens, N. Coleman, B.B. Moore, R.S. Peebles, L.H. Faccioli, and M. Peters-Golden. 2007. Synthetic prostacyclin analogs differentially regulate macrophage function via distinct analog-receptor binding specificities. J. Immunol. 178:1628-1634.
35. Moore, B.B., M.J. Coffey, P. Christensen, S. Sitterding, R. Ngan, C.A. Wilke, R. McDonald, S.M. Phare, M. Peters-Golden, R. Paine III, and G.B. Toews. 2000. GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism. J. Immunol. 165:4032-4039.
36. Medeiros, A.I., A. Sa-Nunes, E.G. Soares, C.M. Peres, C.L. Silva, and L.H. Faccioli. 2004. Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis. Infect. Immun. 72:1637-1644.